Zdrowie i gospodarka · 01/02/2023

FDA Releases Draft Guidance for Externally Controlled Trials of Drug and Biological Products

The FDA is releasing a draft guidance document outlining considerations for designing and conducting externally controlled trials to support the safety and effectiveness of drug products, as part of its Real-World Evidence (RWE) Program.